GSA Capital Partners’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,525
Closed -$18K 1737
2024
Q4
$18K Buy
+1,525
New +$35.2K ﹤0.01% 1555
2024
Q2
Sell
-852
Closed -$49K 1695
2024
Q1
$49K Buy
+852
New +$60.3K ﹤0.01% 1534
2023
Q3
Sell
-2,863
Closed -$207K 1561
2023
Q2
$207K Sell
2,863
-460
-14% -$33.5K 0.02% 1246
2023
Q1
$231K Buy
+3,323
New +$260K 0.02% 1181
2022
Q3
Sell
-5,638
Closed -$761K 1579
2022
Q2
$761K Buy
5,638
+5,082
+914% +$529K 0.11% 262
2022
Q1
$66K Sell
556
-3,020
-84% -$492K 0.01% 1328
2021
Q4
$762K Sell
3,576
-32
-0.9% -$9.8K 0.1% 342
2021
Q3
$1.19M Buy
3,608
+3,203
+791% +$934K 0.12% 226
2021
Q2
$105K Buy
+405
New +$251K 0.01% 1246
2021
Q1
Sell
-757
Closed -$265K 1170
2020
Q4
$265K Buy
+757
New +$299K 0.04% 811

Other funds holding CVM

GSA Capital Partners's CVM Position: Q1 2025 in Review

GSA Capital Partners sold out of CEL-SCI Corp (CVM) in Q1 2025, closing a stake of 1,525 shares — an estimated $18K sold.

GSA Capital Partners first reported a position in CVM in Q4 2020 and held it in 10 quarters. The position peaked at $1.19M in Q3 2021. 49 funds tracked by Wall St. Rank hold CVM as of Q1 2025.

  • GSA Capital Partners reported no remaining CEL-SCI Corp position as of Q1 2025 after selling out during the quarter.
  • GSA Capital Partners sold 1,525 CEL-SCI Corp shares in Q1 2025, an estimated $18K.
  • GSA Capital Partners first reported a position in CEL-SCI Corp in Q4 2020 and held it in 10 quarters.
  • GSA Capital Partners's CEL-SCI Corp position peaked at $1.19M in Q3 2021.
  • 49 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q1 2025.

Based on GSA Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.